UPDATE - UBS Upgrades Gevo (GEVO) to Buy on Recent Sell-off
Get Alerts GEVO Hot Sheet
Price: $1.54 +1.99%
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - UBS upgrades Gevo (Nasdaq: GEVO) from Neutral to Buy. PT $21.
UBS analyst says, "GEVO shares are down ~25% in June. Despite a general “risk off” environment, shares have significantly underperformed peers Amyris Biotechnologies (Nasdaq: AMRS), Codexis (Nasdaq: CDXS) and Solazyme (Nasdaq: SZYM) (down 2% on avg in June). We believe concerns around legislative actions on ethanol and the start of the ASTM bio-jet certific ation process have sown confusion; indeed, a potential elimination of ethanol blending credits should help Gevo (improving its negotiating position with corn ethanol plant owners), while Gevo has proceeded to the next stage of ASTM approval--a 2-year process forecast to conclude in 2013."
UBS analyst says, "GEVO shares are down ~25% in June. Despite a general “risk off” environment, shares have significantly underperformed peers Amyris Biotechnologies (Nasdaq: AMRS), Codexis (Nasdaq: CDXS) and Solazyme (Nasdaq: SZYM) (down 2% on avg in June). We believe concerns around legislative actions on ethanol and the start of the ASTM bio-jet certific ation process have sown confusion; indeed, a potential elimination of ethanol blending credits should help Gevo (improving its negotiating position with corn ethanol plant owners), while Gevo has proceeded to the next stage of ASTM approval--a 2-year process forecast to conclude in 2013."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley Upgrades RF Industries Ltd. (RFIL) to Buy
- Bloom Burton & Co. Upgrades Aurinia Pharmaceuticals (AUPH) to Buy (1)
- JPMorgan Upgrades Deterra Royalties Ltd (DRR:AU) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share